United Capital Financial Advisers, LLC Dare Bioscience, Inc. Transaction History

United Capital Financial Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$0.94 - $1.76 $752 - $1,408	800 Added 5.33%	15,800 $19,000
Q2 2021 Aug 13, 2021	BUY	$1.21 - $1.89 $3,448 - $5,386	2,850 Added 23.46%	15,000 $28,000
Q1 2021 May 14, 2021	SELL	$1.31 - $3.0 $1,310 - $3,000	-1,000 Reduced 7.6%	12,150 $21,000
Q4 2020 Feb 17, 2021	BUY	$0.96 - $1.51 $864 - $1,359	900 Added 7.35%	13,150 $18,000
Q1 2020 May 15, 2020	BUY	$0.79 - $1.7 $1,580 - $3,400	2,000 Added 19.51%	12,250 $10,000

Q2 2019 Aug 13, 2019	BUY	$0.79 - $1.66 $8,097 - $17,015	10,250 New	10,250 $9,000

6.86M

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $28.8M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.